During the past decade, Nambour General Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nambour General Hospital" #1 sponsor was "Biotronik SE & Co. KG" with 2 trials, followed by "Cellxpert Biotechnology Corp." with 2 trials sponsored, "Kirby Institute" with 2 trials sponsored, "The George Institute" with 2 trials sponsored and "The University of New South Wales" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nambour General Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 5 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 2 trials as a collaborator, "Baxter Healthcare Corporation" with 2 trials as a collaborator, "Medigen Biotechnology Corporation" with 2 trials as a collaborator and "Pfizer" with 2 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Nambour General Hospital" are "Heart Failure" (2 trials), "Lung Cancer" (2 trials), "Acute Kidney Injury" (1 trials), "Ankle Fractures" (1 trials) and "Breast Adenocarcinoma" (1 trials). Many other conditions were trialed in "Nambour General Hospital" in a lesser frequency.

Most popular intervention types in "Nambour General Hospital" are "Drug" (12 trials), "Other" (6 trials), "Device" (3 trials), "Procedure" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "PI-88" (2 trials), "Placebo" (2 trials), "docetaxel" (2 trials), "Accelerated RRT initiation" (1 trials) and "Anastrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nambour General Hospital" are 17 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Nambour General Hospital". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Nambour General Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Nambour General Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 5 trials that are defined as “Not Applicable".